Ranked #2,076 of 8,699 institutional investors
NEA Management Company, LLC
Timonium, MD
$1.20B
US stock portfolio at live prices · today −$40.8M (−3.28%)
Live prices, last trade 11:35 AM ET
- Value at quarter end (Q3 2026)
- $1.36B
- Change from Q2 2026
- −$223.8M (−14.09%)
- Positions
- 24 · 0 new, 1 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: none$58.6M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesSGP 18.9%MBX 15.4%TRVI 14.6%SVRA 8.65%ZBIO 8.46%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| SGP SpyGlass Pharma, Inc. | 7,392,301 | $227M | 18.9% | Unchanged |
| MBX MBX Biosciences, Inc. | 3,614,486 | $186M | 15.4% | Unchanged |
| TRVI Trevi Therapeutics, Inc. | 13,222,228 | $176M | 14.6% | Unchanged |
| SVRA Savara Inc. | 24,471,264 | $104M | 8.65% | Unchanged |
| ZBIO Zenas BioPharma, Inc. | 4,023,219 | $102M | 8.46% | Unchanged |
| CELC Celcuity Inc. | 1,710,561 | $93.6M | 7.78% | Unchanged |
| AUPH Aurinia Pharmaceuticals Inc. | 3,969,834 | $58.9M | 4.89% | Unchanged |
| GLUE Monte Rosa Therapeutics, Inc. | 6,692,298 | $58.3M | 4.84% | Reduced −13% |
| COUR Coursera, Inc. | 12,867,769 | $44.5M | 3.70% | Unchanged |
| ORIC ORIC Pharmaceuticals, Inc. | 4,118,621 | $31.0M | 2.58% | Unchanged |
| KRRO Korro Bio, Inc. | 1,297,893 | $16.3M | 1.36% | Unchanged |
| XFOR X4 Pharmaceuticals, Inc. | 3,233,743 | $9.6M | 0.80% | Unchanged |
| PHAT Phathom Pharmaceuticals, Inc. | 1,960,169 | $9.5M | 0.79% | Unchanged |
| CSBR Champions Oncology, Inc. | 1,713,720 | $7.6M | 0.63% | Unchanged |
| BDTX Black Diamond Therapeutics, Inc. | 4,448,757 | $6.1M | 0.50% | Unchanged |
| IVA Inventiva S.A. | 1,462,586 | $4.8M | 0.40% | Unchanged |
| NKTX Nkarta, Inc. | 3,568,781 | $4.2M | 0.35% | Unchanged |
| MRKR Marker Therapeutics, Inc. | 1,625,678 | $1.9M | 0.16% | Unchanged |
| OKUR OnKure Therapeutics, Inc. | 478,548 | $1.3M | 0.11% | Unchanged |
| LONA LeonaBio, Inc. | 464,398 | $1.1M | <0.1% | Unchanged |
| CVRX CVRx, Inc. | 1,954,440 | $1.0M | <0.1% | Unchanged |
| SNTI Senti Biosciences Holdings, Inc. | 114,413 | $288K | <0.1% | Unchanged |
| IMA ImageneBio, Inc. | 50,005 | $192K | <0.1% | Unchanged |
| GOSS Gossamer Bio, Inc. | 12,500 | $142K | <0.1% | Unchanged |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| KPTIQ Karyopharm Therapeutics Inc. | 576,780 | $20K |